Evidence map›Paper›PMID 31127039›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Histone deacetylase 4 promotes type I interferon signaling, restricts DNA viruses, and is degraded via vaccinia virus protein C6.

Yongxu Lu, Jennifer H Stuart, Callum Talbot-Cooper, Shuchi Agrawal-Singh, Brian Huntly, Andrei I Smid, Joseph S Snowden, Liane Dupont, Geoffrey L Smith

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. The strategies and advances of mRNA translation booster.Asian journal of pharmaceutical sciences · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yongxu LuDepartment of Pathology, University of Cambridge, CB2 1QP Cambridge, United Kingdom.ORCID 0000-0003-4701-5560
Jennifer H StuartDepartment of Pathology, University of Cambridge, CB2 1QP Cambridge, United Kingdom.
Callum Talbot-CooperDepartment of Pathology, University of Cambridge, CB2 1QP Cambridge, United Kingdom.
Shuchi Agrawal-SinghCambridge Institute for Medical Research, University of Cambridge, CB2 0XY Cambridge, United Kingdom.
Brian HuntlyCambridge Institute for Medical Research, University of Cambridge, CB2 0XY Cambridge, United Kingdom.
Andrei I SmidDepartment of Pathology, University of Cambridge, CB2 1QP Cambridge, United Kingdom.ORCID 0000-0001-9732-0059
Joseph S SnowdenDepartment of Pathology, University of Cambridge, CB2 1QP Cambridge, United Kingdom.ORCID 0000-0001-7857-0634
Liane DupontDepartment of Pathology, University of Cambridge, CB2 1QP Cambridge, United Kingdom.
Geoffrey L SmithDepartment of Pathology, University of Cambridge, CB2 1QP Cambridge, United Kingdom; gls37@cam.ac.uk.ORCID 0000-0002-3730-9955
University of Cambridge · GB

Funding

Biotechnology and Biological Sciences Research Council BB/M011194/1Cancer Research UK 25508Medical Research Council MC_PC_12009Medical Research Council MR/R009708/1Wellcome Trust
6 · The paper itself

Abstract

Interferons (IFNs) represent an important host defense against viruses. Type I IFNs induce JAK-STAT signaling and expression of IFN-stimulated genes (ISGs), which mediate antiviral activity. Histone deacetylases (HDACs) perform multiple functions in regulating gene expression and some class I HDACs and the class IV HDAC, HDAC11, influence type I IFN signaling. Here, HDAC4, a class II HDAC, is shown to promote type I IFN signaling and coprecipitate with STAT2. Pharmacological inhibition of class II HDAC activity, or knockout of HDAC4 from HEK-293T and HeLa cells, caused a defective response to IFN-α. This defect in HDAC4

Indexed as

Cell LineCell Line, TumorDNA VirusesHEK293 CellsHeLa CellsHerpesvirus 1, HumanHistone DeacetylasesHumansInterferon Type IRepressor ProteinsSignal TransductionVacciniaVaccinia virusViral ProteinsVirus ReplicationHDAC4 protein, humanHistone DeacetylasesInterferon Type IRepressor ProteinsViral Proteinshistone deactylase 4immune evasionSTAT2 recruitmenttype I interferon signalingvaccinia virus protein C6

Identifiers

PMID31127039
PMCPMC6575207
OpenAlexW2945621539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.